Clinical Trial Update: Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania [NA]

View source ↗

Summary

This clinical trial update describes an ongoing study in Tanzania to optimize HIV pre-exposure prophylaxis (PrEP) among women who use drugs. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mental Disorders
• Substance Use Disorders

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: HIV, Mental Health | NA | Status: ACTIVE_NOT_RECRUITING